Articles from Y-Prime, LLC

New capability enables teams to define eCOA calculation logic through natural language, reducing build time while improving accuracy and consistency throughout the study

New capability embeds structured engagement directly within eCOA workflows to strengthen adherence and protect endpoint integrity

MALVERN, Pa., Dec. 09, 2025 (GLOBE NEWSWIRE) -- YPrime, a proven leader in clinical trial technology, today announced it has received two distinctions in the 2025 Clinical Trials Arena Excellence Awards: Innovation for AI in Clinical Trials and Environmental Excellence for Sustainable Trials. Powered by GlobalData’s independent research, the Clinical Trials Arena Excellence Awards recognize organizations advancing meaningful progress across the clinical research ecosystem.

New data reveals how AI applied to eCOA localization improves accuracy, accelerates startup, and expands global trial inclusion

New functionality aligns with EMA, FDA, and ICH E6(R3) expectations for documented investigator review, endorsement, and sign-off of participant data

MALVERN, Pa., Sept. 23, 2025 (GLOBE NEWSWIRE) -- YPrime, a proven leader in clinical trial technology, today announced the release of its first Environmental, Social, and Governance (ESG) Report. The report highlights measurable progress across environmental stewardship, social impact, and governance practices, reflecting the company’s long-standing belief that responsible innovation drives long-term business value.

Recognition highlights the strength of YPrime’s eCOA platform in delivering faster, more flexible global trials with high-quality data

MALVERN, Pa., March 12, 2025 (GLOBE NEWSWIRE) -- YPrime, the leading pioneer in clinical trial technology, today announced it has earned a top-tier EcoVadis rating and medal, solidifying its position among the industry’s most responsible and sustainable organizations. YPrime ranked in the top 35 percent globally, placing it ahead of the majority of 157,000 companies assessed worldwide. This marks a 27-point increase from the previous year, underscoring YPrime’s significant progress in Environmental, Social, and Governance (ESG) performance.

AI-powered localization supports globalization of studies, accelerating startups, ensuring quality, and reducing delays and costs

Innovative solution streamlines data control for clinical trial sites, reducing time required for data changes from days or weeks to minutes

Recognition Highlights YPrime's Commitment to Patient-Focused eCOA Innovation

New YPrime report offers guidance to sponsors on enhancing site and patient technology experience to increase overall trial efficiency

Prestigious Distinction Highlights YPrime's Innovative Approach to Enhancing Clinical Trial Participation with Industry-Leading eCOA

YPrime’s eCOA Now Offers Unmatched 100% Configurability and User-Centric Design—Enabling Faster Study Startup, High-Quality Data, and Operational Efficiencies

New Findings Highlight the Importance of Therapeutic Area-Specific Solutions and Collaborative Approaches in Advancing Endocrinology Research

Developed in Partnership with Patients, New Solution Enhances Data Quality, Patient Compliance, and Diary Adherence

Seasoned HR Executive Joins YPrime to Align People Strategy with Business Priorities and Strengthen Culture

Collaborative research with clinical trial professionals identifies ways eCOA can contribute to faster neurological breakthroughs

New assessment enables faster, more accurate, and user-friendly data collection to accelerate clinical research

Survey explores how eCOA enhances patient experience and reduces risk and uncertainty

Poor operational efficiency driving the need to increase start-up and protocol amendment implementation speed

Clinical trial technology leader amplifies its dedication to empowering researchers and revolutionizing the clinical trial landscape